Copyright: ©Author(s) 2026.
World J Gastroenterol. Apr 14, 2026; 32(14): 114331
Published online Apr 14, 2026. doi: 10.3748/wjg.v32.i14.114331
Published online Apr 14, 2026. doi: 10.3748/wjg.v32.i14.114331
Figure 1 Xiangshaliujunzi decoction suppressed cell viability, cell proliferation and promoted apoptosis in a dose-dependent manner.
A: Cell viability detected by CCK8 assays; B: Cell proliferation detected by colony formation assays; C: Cell apoptosis detected by flow cytometry. L-Xiangshaliujunzi decoction (XSLJZD): 1.55 g/(kg·day); M-XSLJZD: 3.1 g/(kg·day); H-XSLJZD: 6.2 g/(kg·day). The vertical axis represents optical density at 450 nm from CCK-8 assays (A), normalized to the control at 0 hour (set as 1). aP < 0.05, bP < 0.01 vs control. One-way ANOVA with Tukey's post-hoc test was used. XSLJZD: Xiangshaliujunzi decoction.
- Citation: Gao H, Yin DF, Xing XR, Zhou LJ, Yu R. MiR-200a-3p/ZEB1/IRF1-mediated PANoptosis prompts Xiangshaliujunzi decoction to overcome 5-fluorouracil resistance in gastric cancer. World J Gastroenterol 2026; 32(14): 114331
- URL: https://www.wjgnet.com/1007-9327/full/v32/i14/114331.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i14.114331